Spectrum Pharmaceuticals (SPPI)
Add to Watchlists Create an Alert
8.33
-0.22 -2.57%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Spectrum Pharmaceuticals Free Cash Flow:
8.089M for Dec. 31, 2012Spectrum Pharmaceuticals Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 8.089M |
| Sept. 30, 2012 | 18.91M |
| June 30, 2012 | 17.83M |
| March 31, 2012 | 26.81M |
| Dec. 31, 2011 | 10.87M |
| Sept. 30, 2011 | 19.99M |
| June 30, 2011 | 28.48M |
| March 31, 2011 | -16.53M |
| Dec. 31, 2010 | 10.10M |
| Sept. 30, 2010 | -2.981M |
| June 30, 2010 | -4.928M |
| March 31, 2010 | -26.31M |
| Dec. 31, 2009 | -11.22M |
| Sept. 30, 2009 | -11.04M |
| June 30, 2009 | 3.802M |
| March 31, 2009 | 0.143M |
| Dec. 31, 2008 | -5.71M |
| Sept. 30, 2008 | -7.462M |
| June 30, 2008 | 10.90M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Dec. 31, 1999 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
SPPI Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Elan | -28.50M |
| Agenus | -3.280M |
| Biocryst Pharmaceuticals |
SPPI Free Cash Flow Rankings
| Overall |
80th percentile 1550 of 8009 |
| Sector |
79th percentile 140 of 687 in Healthcare |
| Industry |
89th percentile 25 of 248 in Biotechnology |
SPPI Free Cash Flow Range, Past 5 Years
| Minimum | -26.31M | Mar 2010 |
| Maximum | 28.48M | Jun 2011 |
| Average | 3.672M |
